Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Pacific Biosciences of California Inc
NASDAQ:PACB
Pacific Biosciences of California Inc
NASDAQ:PACB
Price:
2.36
USD
4.42%
Market Closed
Market Cap:
$733.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
PACB Price Forecast
Based on 9 analysts
Based on 9 analysts
+30% Upside
from
$2.36
today
Pacific Biosciences of California Inc (PACB)’s 12-month stock price forecast through November 2027 has a consensus target of $3.06, implying 30% upside. The forecast is based on price targets from 9 Wall Street analysts.
PACB Analyst Rating
Based on 8 analysts
Based on 8 analysts
Analysts rate PACB Buy, with 4 of 8 recommending Buy or Strong buy.
Pacific Biosciences of California Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PACB's stock price target?
Price Target
3.06
USD
3.06
USD
According to Wall Street analysts, the average 1-year price target for PACB is 3.06 USD with a low forecast of 2.02 USD and a high forecast of 3.2 USD.
What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
17%
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Gross Profit forecast for Pacific Biosciences of California Inc?
Projected CAGR
26%
26%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 3 years is 26%.
